SENORES PHARMACEUTICALS L (SENORES) — Net Asset Quality Index
SENORES PHARMACEUTICALS L (SENORES) has a Net Asset Quality Index of 60.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs16.04 Billion minus total liabilities of Rs6.39 Billion yields net assets of Rs9.65 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check SENORES PHARMACEUTICALS L (SENORES) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
SENORES PHARMACEUTICALS L Net Asset Quality Index Over Time (2022–2026)
This chart shows how SENORES PHARMACEUTICALS L's Net Asset Quality Index has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the index stands at 60.1%, representing net assets of Rs9.65 Billion against total assets of Rs16.04 Billion INR. See SENORES book value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for SENORES PHARMACEUTICALS L (2022–2026)
The table below presents the year-by-year Net Asset Quality Index for SENORES PHARMACEUTICALS L from 2022 to 2026, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of SENORES PHARMACEUTICALS L.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 60.1% | Rs9.65 Billion | Rs16.04 Billion | Rs6.39 Billion | ▼ -5.1 pp |
| 2025 | 65.2% | Rs94.96 Million | Rs145.66 Million | Rs50.70 Million | ▲ +27.9 pp |
| 2024 | 37.3% | Rs2.32 Billion | Rs6.22 Billion | Rs3.90 Billion | ▲ +2.5 pp |
| 2023 | 34.7% | Rs454.99 Million | Rs1.31 Billion | Rs855.54 Million | ▼ -27.1 pp |
| 2022 | 61.9% | Rs365.90 Million | Rs591.52 Million | Rs225.62 Million | — |